Anti-PLA2R1 Antibodies Containing Sera Induce In Vitro Cytotoxicity Mediated by Complement Activation

Table 1

Clinical characteristics of patients in the study.

Clinical characteristics	Cohort SOURIS (48 patients)
Age (years)
Gender ratio (M/F)	3.3
LOCF (months)	14 (3; 18)
Proteinuria at baseline (g/g)	5.1 (3.5; 7.2)
Serum albumin at baseline (g/l)	23.9 (21.2; 29.7)
Serum creatinine at baseline (μmol/l)	103 (84.7; 135)
Proteinuria at LOCF (g/g)	1.9 (0.3; 3.4)
Patients treated with rituximab	37
Patients treated with other immunosuppressors (Ponticelli)	4

Data are presented as or as median and interquartile range. LOCF: last observation carried forward.